Claim Ledger
A public index of reviewed claim statements connected to source, study, topic, signal, and scorecard records.
Claims
159
Supported
31
High overclaim risk
11
Sources linked
185
Studies linked
158
VV Claim Boundary Matrix v1.0
Claim Integrity Score summarizes source quality, applicability, boundary clarity, overclaim containment, harm-risk handling, and graph support. Public votes help prioritize review; they do not change evidence confidence or the score.
Submissions go to intake. Public pages only render reviewed canonical repo claims.
Integrity
88/100
Strongly Supported Claim
Sustained fat loss requires net energy deficit, but the appetite, expenditure, adaptation, and maintenance systems that shape that deficit are biologically regulated.
2 sources / 1 studies
Integrity
90/100
Strongly Supported Claim
Calories describe the accounting of tissue-energy change, but they do not explain all biological friction around appetite, expenditure, adaptation, food environment, hormones, sleep, lean mass, and maintenance.
3 sources / 3 studies
Integrity
84/100
Supported With Boundaries
Ultra-processed diets can increase spontaneous calorie intake and weight gain under controlled inpatient conditions, even when presented diets are broadly matched for macronutrients, sugar, sodium, and fiber.
1 sources / 1 studies
Integrity
79/100
Supported With Boundaries
Large weight loss can reduce resting energy expenditure beyond what body-size change alone predicts, illustrating that calories-out is adaptive rather than fixed.
2 sources / 1 studies
Integrity
84/100
Supported With Boundaries
Insulin and carbohydrate quality matter, but controlled feeding evidence does not support a simple insulin-only explanation of obesity or fat loss.
2 sources / 1 studies
Integrity
83/100
Supported With Boundaries
Hypothyroidism can contribute to weight gain by lowering calorie expenditure, but typical thyroid-related weight change is often bounded and should not be used as a universal explanation for weight gain.
1 sources / 1 studies
Integrity
81/100
Supported With Boundaries
Sleep restriction can affect appetite-regulating signals and hunger, making sleep relevant to weight-management behavior and adherence.
2 sources / 1 studies
Integrity
85/100
Strongly Supported Claim
Low-fat and low-carbohydrate patterns can both support weight loss, but group-average diet labels are less useful than adherence, food quality, calorie intake, and individual fit.
2 sources / 2 studies
Integrity
87/100
Strongly Supported Claim
Semaglutide and tirzepatide produce clinically meaningful average weight loss in studied adults with obesity or overweight, with results and tolerability varying by drug, dose, and patient context.
2 sources / 2 studies
Integrity
85/100
Strongly Supported Claim
GLP-1-based therapies have demonstrated outcome benefits beyond weight loss in specific high-risk cardiometabolic populations.
3 sources / 3 studies
Integrity
82/100
Supported With Boundaries
Weight maintenance commonly depends on continued treatment, while optimal long-term strategies and lean-mass preservation remain active evidence gaps.
2 sources / 2 studies
Integrity
87/100
Strongly Supported Claim
Semaglutide reduced body weight in adults with obesity or overweight in randomized clinical-trial populations.
2 sources / 1 studies
Integrity
86/100
Strongly Supported Claim
Tirzepatide reduced body weight in adults with obesity or overweight in randomized clinical-trial populations.
1 sources / 1 studies
Integrity
84/100
Supported With Boundaries
Semaglutide reduced major adverse cardiovascular events in SELECT participants with overweight or obesity and established cardiovascular disease without diabetes.
3 sources / 1 studies
Integrity
82/100
Supported With Boundaries
Semaglutide improved kidney outcomes in FLOW participants with type 2 diabetes and chronic kidney disease.
2 sources / 1 studies
Integrity
86/100
Strongly Supported Claim
Tirzepatide improved obstructive sleep apnea outcomes in adults with obesity in SURMOUNT-OSA.
3 sources / 1 studies
Integrity
84/100
Supported With Boundaries
Semaglutide has phase 3 MASH evidence and regulatory relevance for a defined noncirrhotic population with fibrosis.
3 sources / 1 studies
Integrity
79/100
Supported With Boundaries
Lean-mass preservation requires attention during GLP-1-associated weight loss, especially when frailty, low protein intake, or inadequate resistance training are concerns.
2 sources / 1 studies
Integrity
88/100
Strongly Supported Claim
GLP-1 therapies have meaningful gastrointestinal adverse effects and label-level tolerability considerations.
2 sources / 2 studies
Integrity
86/100
Strongly Supported Claim
Gallbladder events, pancreatitis warnings, kidney injury risk, hypoglycemia with certain concomitant drugs, and contraindication context matter in GLP-1 treatment decisions.
4 sources / 1 studies
Integrity
90/100
Strongly Supported Claim
FDA-approved GLP-1 products and compounded, unapproved, or falsely labeled products are different regulatory and quality-risk categories.
4 sources / 1 studies
Integrity
85/100
Strongly Supported Claim
Cost, access, adherence, tolerability, and long-term maintenance materially affect the real-world value of GLP-1 therapy.
2 sources / 2 studies
Integrity
82/100
Supported With Boundaries
Public GLP-1 claims are distorted by both promotional hype and categorical backlash, neither of which substitutes for indication-specific evidence.
3 sources / 2 studies
Integrity
90/100
Strongly Supported Claim
Semaglutide and tirzepatide should not be collapsed into one generic claim because their mechanisms, labels, trial programs, and outcome evidence differ.
4 sources / 2 studies
Integrity
79/100
Supported With Boundaries
Early randomized human studies suggest GLP-1 receptor agonists may reduce some alcohol craving or drinking outcomes, but the evidence is not yet sufficient for routine addiction treatment.
3 sources / 3 studies
Integrity
67/100
Partly Supported / Context-Dependent
Observational studies report associations between GLP-1 use and several substance-use outcomes, but they cannot establish causality or treatment effectiveness.
3 sources / 3 studies
Integrity
60/100
Partly Supported / Context-Dependent
GLP-1 signaling may modulate reward-related circuits, but GLP-1 medicines are not dopamine blockers and mechanistic plausibility is not proof of clinical benefit.
1 sources / 1 studies
Integrity
81/100
Supported With Boundaries
The carnivore diet evidence base is still limited, with direct human evidence dominated by surveys, case reports, case series, nutrient modeling, exploratory studies, and indirect mechanistic evidence rather than long-term randomized outcome trials.
6 sources / 6 studies
Integrity
71/100
Supported With Boundaries
Carnivore-style eating may improve weight or glycemic markers in selected people through severe carbohydrate restriction, calorie-intake changes, food elimination, ketosis, and adherence effects, but carnivore-specific causal evidence remains weak.
3 sources / 3 studies
Integrity
80/100
Supported With Boundaries
Lipid response to carnivore diets appears heterogeneous, with direct evidence and indirect low-carbohydrate evidence supporting caution around LDL-C, total cholesterol, triglycerides, and long-term cardiovascular-risk interpretation.
3 sources / 3 studies
Integrity
81/100
Supported With Boundaries
Carnivore nutrient adequacy depends heavily on food selection, organ-meat use, seafood intake, dairy inclusion, fortification or supplementation, and total intake, while strict zero-plant versions inherently remove dietary fiber and many plant-associated nutrient sources.
3 sources / 3 studies
Integrity
69/100
Partly Supported / Context-Dependent
Plant-free and animal-heavy diets can alter the gut microbiome, but the long-term health meaning of carnivore-associated microbiome changes remains uncertain.
2 sources / 2 studies
Integrity
60/100
Partly Supported / Context-Dependent
Carnivore-ketogenic elimination patterns have low-level case-series evidence for symptom improvement in selected inflammatory bowel disease contexts, but this does not establish general efficacy.
2 sources / 2 studies
Integrity
76/100
Supported With Boundaries
Carnivore-style patterns warrant special caution in people with chronic kidney disease, kidney-stone history, gout risk, high sodium intake, adverse urine-chemistry profiles, diabetes medication use, severe hyperlipidemia, or eating-disorder vulnerability.
2 sources / 2 studies
Integrity
87/100
Strongly Supported Claim
Strict carnivore and zero-plant eating conflict with current U.S. dietary guidance emphasizing whole nutrient-dense foods including vegetables, fruits, healthy fats, dairy, protein foods, and whole grains.
3 sources / 3 studies
Integrity
85/100
Strongly Supported Claim
A strict carnivore-diet experiment is more defensible when treated as a monitored intervention with baseline and follow-up labs, symptom tracking, medication review, and clear stopping rules rather than as a blanket lifestyle cure.
4 sources / 4 studies
Integrity
78/100
Supported With Boundaries
Sleep duration is associated with all-cause mortality in a U-shaped pattern in prospective cohort meta-analysis, with both short and long sleep linked to higher mortality risk versus roughly 7 hours, but causality is not proven.
1 sources / 1 studies
Integrity
82/100
Supported With Boundaries
Objective sleep regularity is associated with all-cause and cause-specific mortality risk, and may capture a health-relevant sleep dimension that average duration alone misses.
2 sources / 2 studies
Integrity
60/100
Partly Supported / Context-Dependent
Sleep disturbance has biologically plausible links to inflammatory and immune dysregulation through cytokine, neuroendocrine, autonomic, and antiviral-response pathways, but inflammation mediation between sleep and mortality is not settled.
1 sources / 1 studies
Integrity
87/100
Strongly Supported Claim
Sleep duration, sleep quality, and sleep regularity are distinct dimensions of sleep health, and consumer claims should avoid treating hours slept as the whole sleep signal.
3 sources / 3 studies
Integrity
76/100
Supported With Boundaries
Longitudinal commercial wearable sleep data can reveal associations between sleep duration, irregularity, sleep stages, and chronic disease incidence, but wearable sleep scores should not be treated as clinical-grade diagnosis.
1 sources / 1 studies
Integrity
83/100
Supported With Boundaries
Improving sleep duration, quality, or regularity is a plausible health intervention, but direct evidence that consumer sleep improvement lowers all-cause mortality remains under-proven.
3 sources / 3 studies
Integrity
80/100
Supported With Boundaries
Seed oils are not supported as toxic at normal dietary exposure, though the food pattern they often appear in can still be low-quality.
3 sources / 2 studies
Integrity
80/100
Supported With Boundaries
The blanket claim that seed oils cause inflammation is not supported by human trial-review evidence on linoleic acid and inflammatory markers in healthy adults.
2 sources / 1 studies
Integrity
78/100
Supported With Boundaries
Omega-6 fats are not inherently pro-inflammatory in the simple viral sense; mechanistic plausibility does not override human outcome and marker evidence.
2 sources / 2 studies
Integrity
82/100
Supported With Boundaries
The claim that seed oils cause heart disease is too broad, especially when unsaturated fats replace saturated fats rather than being added through ultra-processed foods.
2 sources / 2 studies
Integrity
73/100
Supported With Boundaries
Beef tallow is not automatically healthier than seed oils; heat stability, saturated fat exposure, LDL response, dose, and dietary pattern change the answer.
1 sources / 1 studies
Integrity
71/100
Supported With Boundaries
Canola oil being industrially processed is not by itself a clinical harm endpoint.
2 sources / 1 studies
Integrity
70/100
Supported With Boundaries
Seed-oil oxidation concerns are most plausible in repeated high-heat frying and poor-storage contexts, not as a blanket indictment of ordinary culinary use.
2 sources / 1 studies
Integrity
77/100
Supported With Boundaries
The omega-6 to omega-3 ratio can be a dietary-pattern clue, but it is overclaimed when treated as the main disease switch by itself.
2 sources / 2 studies
Integrity
79/100
Supported With Boundaries
Seed oils may be more useful as a marker of ultra-processed food exposure than as the independent cause of poor metabolic health.
2 sources / 1 studies
Integrity
60/100
Partly Supported / Context-Dependent
Avoiding seed oils is not proven to fix obesity or metabolic disease by itself.
2 sources / 2 studies
Integrity
81/100
Supported With Boundaries
The claim that sunscreen causes cancer is unsupported and risky; UV exposure is the better-established skin-damage and skin-cancer risk.
3 sources / 2 studies
Integrity
79/100
Supported With Boundaries
Real-world sunscreen use does not appear to routinely cause vitamin D deficiency, though vitamin D status still depends on individual context.
1 sources / 1 studies
Integrity
82/100
Supported With Boundaries
Natural sun exposure can still damage skin, and naturalness is not evidence that sunscreen is unnecessary.
2 sources / 1 studies
Integrity
71/100
Supported With Boundaries
Some chemical sunscreen filters need more safety data and can be systemically absorbed, but absorption alone does not prove clinical endocrine harm.
3 sources / 3 studies
Integrity
77/100
Supported With Boundaries
Mineral sunscreen is the clearest conservative fallback, but the evidence does not prove that only mineral sunscreen is safe.
2 sources / 1 studies
Integrity
79/100
Supported With Boundaries
Several sunscreen active ingredients can enter the bloodstream under maximal-use conditions, but the clinical significance remains under study.
3 sources / 2 studies
Integrity
80/100
Supported With Boundaries
SPF 100 should not be interpreted as twice the real-world protection of SPF 50 because application amount, reapplication, UVA coverage, and behavior matter.
2 sources / 1 studies
Integrity
77/100
Supported With Boundaries
Darker skin has more baseline melanin protection but still can experience UV damage, hyperpigmentation, photoaging, and skin cancer.
2 sources / 1 studies
Integrity
83/100
Supported With Boundaries
Coconut oil, beef tallow, and DIY oils are not validated replacements for broad-spectrum sunscreen.
2 sources / 2 studies
Integrity
83/100
Supported With Boundaries
Sunscreen alone is an incomplete sun-protection strategy; shade, clothing, hats, sunglasses, timing, and avoiding burns also matter.
3 sources / 1 studies
Integrity
88/100
Strongly Supported Claim
Alkaline water can change urine chemistry in some contexts, but it does not meaningfully alkalize blood or override normal acid-base regulation in healthy people.
3 sources / 2 studies
Integrity
85/100
Strongly Supported Claim
Urine pH strips can show dietary acid-base changes, but urine pH is not proof that the blood, tumors, or the whole body have been alkalized.
2 sources / 1 studies
Integrity
86/100
Strongly Supported Claim
Evidence does not support alkaline diets or alkaline water as cancer prevention or cancer treatment, despite real research interest in tumor acidity and metabolism.
3 sources / 1 studies
Integrity
84/100
Supported With Boundaries
The claim that cancer cannot live in an alkaline body is an overextension of tumor-microenvironment biology and is not achieved by drinking alkaline water or eating alkaline foods.
2 sources / 1 studies
Integrity
78/100
Supported With Boundaries
High-pH or bicarbonate-rich water may help some reflux or heartburn contexts through stomach-adjacent mechanisms such as pepsin inactivation or buffering, but it is not a general GERD cure.
2 sources / 2 studies
Integrity
75/100
Supported With Boundaries
Urine alkalinization can matter for some stone types, but commercial alkaline waters often provide too little alkali to replace clinician-directed stone prevention strategies.
1 sources / 1 studies
Integrity
78/100
Supported With Boundaries
Bicarbonate-rich mineral water can raise urine pH and reduce net acid excretion in some contexts, but this is narrower than universal alkaline-health marketing.
2 sources / 2 studies
Integrity
64/100
Partly Supported / Context-Dependent
Small exercise studies suggest possible hydration or anaerobic-performance markers from alkaline water, but the evidence is not strong enough for broad performance or health claims.
1 sources / 1 studies
Integrity
80/100
Supported With Boundaries
The claim that acid-forming foods directly destroy bones is overstated; bone health depends on many inputs beyond dietary acid load.
1 sources / 1 studies
Integrity
84/100
Supported With Boundaries
Fruits and vegetables can support health, but their benefit is more plausibly explained by nutrients, fiber, potassium, and diet quality than by mystical body alkalization.
2 sources / 2 studies
Integrity
87/100
Strongly Supported Claim
Vegan diets are not automatically healthier; outcomes depend on food quality, adequacy, supplementation, energy intake, and what the vegan diet replaces.
2 sources / 2 studies
Integrity
86/100
Strongly Supported Claim
Vegetarian and vegan diets can lower LDL-C and apoB on average in randomized trials, especially when they improve saturated-fat and fiber patterns.
2 sources / 2 studies
Integrity
81/100
Supported With Boundaries
A healthy vegan diet can improve several cardiometabolic markers over weeks, but short-term biomarker gains are not the same as guaranteed long-term outcomes for every vegan diet.
2 sources / 2 studies
Integrity
81/100
Supported With Boundaries
Vegan diets are not protein-deficient by default, but protein amount, quality, leucine density, and calorie sufficiency require planning in athletes, older adults, and dieting phases.
2 sources / 2 studies
Integrity
90/100
Strongly Supported Claim
Vegans generally need reliable vitamin B12 from supplements or fortified foods; treating B12 as optional is a high-risk vegan diet mistake.
3 sources / 2 studies
Integrity
81/100
Supported With Boundaries
Healthy plant-based patterns are generally associated with lower type 2 diabetes risk, while unhealthy plant-based patterns can weaken or reverse that signal.
2 sources / 2 studies
Integrity
79/100
Supported With Boundaries
Some cohorts report higher fracture risk in vegans or non-meat eaters, especially hip fracture signals, but the mechanism likely involves BMI, calcium, vitamin D, protein, and other confounders rather than veganism alone.
2 sources / 2 studies
Integrity
58/100
Partly Supported / Context-Dependent
Evidence does not cleanly show that vegan diets cause depression; mental-health associations are mixed and confounded by motivation, restriction, baseline traits, and diet quality.
1 sources / 1 studies
Integrity
78/100
Supported With Boundaries
Plant-based meats vary widely; they should be judged by saturated fat, sodium, protein, fiber, processing, and what they replace rather than dismissed or endorsed by label alone.
1 sources / 1 studies
Integrity
80/100
Supported With Boundaries
Vegan diets may be appropriate across life stages when carefully planned, but life-stage safety claims should explicitly account for B12, iodine, calcium, vitamin D, iron, zinc, omega-3, protein, and clinical context.
3 sources / 3 studies
Integrity
78/100
Supported With Boundaries
There is no credible clinical evidence that perineum tanning uniquely increases energy beyond ordinary light exposure, placebo, novelty, relaxation, or being outside.
1 sources / 1 studies
Integrity
80/100
Supported With Boundaries
No credible clinical evidence shows that perineal UV exposure improves hormones compared with ordinary daylight, sleep, exercise, nutrition, or correcting deficiency states.
2 sources / 2 studies
Integrity
83/100
Supported With Boundaries
There is no evidence that the perineum is a superior or necessary site for vitamin D production or sunlight benefits.
3 sources / 2 studies
Integrity
76/100
Supported With Boundaries
An ancient-practice claim does not establish safety or efficacy for perineum sunning under modern dermatology standards.
2 sources / 1 studies
Integrity
79/100
Supported With Boundaries
Brief perineum sun exposure has no proven benefit and may burn sensitive, usually unexposed skin; risk depends on dose, UV index, skin type, and history.
3 sources / 2 studies
Integrity
85/100
Strongly Supported Claim
A tan provides only minimal protection and should not be treated as meaningful SPF or as a safe skin-cancer prevention strategy.
2 sources / 2 studies
Integrity
87/100
Strongly Supported Claim
Real-world sunscreen use generally does not eliminate vitamin D status, and vitamin D can be addressed with testing, diet, fortified foods, or supplements instead of intentional tanning.
3 sources / 3 studies
Integrity
81/100
Supported With Boundaries
Perineum tanning is not just harmless eccentric wellness because it encourages intentional UV exposure to sensitive skin without demonstrated benefit.
3 sources / 3 studies
Integrity
84/100
Supported With Boundaries
Sunlight is not always bad; ordinary daylight can support circadian rhythm and vitamin D biology, but UV dose, timing, skin type, and burn avoidance matter.
3 sources / 2 studies
Integrity
86/100
Strongly Supported Claim
Tanning beds are not a safer substitute for perineum sunning or sunlight; UV-emitting tanning devices increase dermatologic risk and are classified as carcinogenic exposures.
3 sources / 3 studies
Integrity
86/100
Strongly Supported Claim
Community water fluoridation has evidence for reducing dental caries at the population level, especially where preventive dental access is uneven.
4 sources / 4 studies
Integrity
70/100
Supported With Boundaries
The strongest fluoride neurodevelopment concern is dose-sensitive and concentrated around higher total exposure, not a blanket proof that every fluoridated water system lowers IQ.
4 sources / 4 studies
Integrity
71/100
Supported With Boundaries
Evidence is not strong enough to conclude that the U.S. recommended community-water level around 0.7 mg/L causes lower IQ, even though higher-exposure findings justify scrutiny.
4 sources / 4 studies
Integrity
82/100
Supported With Boundaries
Total fluoride exposure matters more than a single source because water, toothpaste swallowing, infant formula mixing, tea, supplements, foods, and groundwater can add together.
4 sources / 4 studies
Integrity
85/100
Strongly Supported Claim
Dental fluorosis is the clearest established excess-exposure signal for fluoride, but mild cosmetic fluorosis is different from severe fluorosis or neurodevelopment claims.
3 sources / 3 studies
Integrity
76/100
Supported With Boundaries
The forced-medication objection is an ethics and governance claim, not a direct biological toxicity claim, and it should be argued separately from caries or IQ evidence.
3 sources / 3 studies
Integrity
84/100
Supported With Boundaries
Topical fluoride exposure at the tooth surface and swallowed fluoride exposure should be separated because they have different benefit, dose, and risk questions.
3 sources / 3 studies
Integrity
74/100
Supported With Boundaries
Switching to bottled water does not automatically eliminate fluoride exposure because fluoride content varies by product, source water, labeling, and filtration method.
3 sources / 3 studies
Integrity
67/100
Partly Supported / Context-Dependent
Cancer is not the strongest current fluoride safety signal compared with dental fluorosis and neurodevelopment debates, so broad fluoride-cancer claims need specific endpoint evidence.
3 sources / 3 studies
Integrity
77/100
Supported With Boundaries
Removing water fluoridation can affect dental equity if communities do not replace population-level protection with accessible prevention, dental care, and targeted oral-health support.
3 sources / 3 studies
Integrity
84/100
Supported With Boundaries
Damp buildings and mold exposure are best supported as respiratory, asthma, allergy, and irritation risks, especially for susceptible people.
4 sources / 4 studies
Integrity
57/100
Partly Supported / Context-Dependent
Mold is overclaimed when it is presented as the default explanation for brain fog, fatigue, hormone symptoms, autoimmune disease, or weight gain without stronger individual evidence.
3 sources / 3 studies
Integrity
80/100
Supported With Boundaries
Routine home mold testing is not the priority when mold is visible or smelled because moisture control and removal matter more than species identification for most consumers.
3 sources / 3 studies
Integrity
87/100
Strongly Supported Claim
Moisture control is the central mold-remediation priority because mold growth returns when leaks, humidity, condensation, or water damage remain unresolved.
4 sources / 4 studies
Integrity
79/100
Supported With Boundaries
Black mold panic is over-simplified because color alone does not determine health risk, and dampness, exposure extent, vulnerability, and remediation quality matter more.
3 sources / 3 studies
Integrity
56/100
Partly Supported / Context-Dependent
Binder and mold-detox protocols have thin evidence for broad consumer mold illness claims and should not replace remediation, exposure reduction, or medical evaluation.
3 sources / 3 studies
Integrity
85/100
Strongly Supported Claim
Mold and damp indoor conditions can worsen asthma or respiratory symptoms in susceptible people, making exposure reduction clinically relevant.
4 sources / 4 studies
Integrity
78/100
Supported With Boundaries
Air purifiers can reduce some airborne particles but do not fix mold when the water source, contaminated material, or growth reservoir remains in place.
3 sources / 3 studies
Integrity
77/100
Supported With Boundaries
Bleach is not a universal mold fix because remediation depends on surface type, moisture source, contamination depth, ventilation, and safe cleanup procedure.
3 sources / 3 studies
Integrity
60/100
Partly Supported / Context-Dependent
Mold-cancer claims need specific exposure, mycotoxin, route, dose, and cancer endpoint evidence rather than broad claims that indoor mold generally causes cancer.
3 sources / 3 studies
Integrity
63/100
Partly Supported / Context-Dependent
Direct evidence for mouth taping is limited to small, selected, short-term studies and does not support broad sleep, HRV, oxygenation, jawline, or recovery claims.
3 sources / 3 studies
Integrity
64/100
Partly Supported / Context-Dependent
Mouth taping has only a narrow preliminary signal in selected mild obstructive sleep apnea or mouth-breathing contexts, not a general sleep-apnea treatment claim.
3 sources / 3 studies
Integrity
79/100
Supported With Boundaries
Mouth taping should not be treated as a sleep-apnea treatment because obstructive sleep apnea requires proper screening, diagnosis, and evidence-based management.
4 sources / 4 studies
Integrity
77/100
Supported With Boundaries
Mouth taping can be inappropriate when nasal obstruction, congestion, reflux or vomiting risk, sedatives, alcohol, panic reactions, or respiratory disease are present.
4 sources / 4 studies
Integrity
72/100
Supported With Boundaries
Nasal breathing has real physiology, but that does not automatically validate taping the mouth shut as an effective or safe nightly intervention.
3 sources / 3 studies
Integrity
51/100
Uncertain Claim
Claims that adult mouth taping reshapes the jawline or face are unsupported and should not be presented as a cosmetic or masculinity protocol.
3 sources / 3 studies
Integrity
84/100
Supported With Boundaries
Nighttime mouth breathing can signal an underlying issue such as congestion, allergies, anatomy, medication-related dry mouth, reflux, or sleep-disordered breathing.
4 sources / 4 studies
Integrity
53/100
Uncertain Claim
Claims that mouth taping reliably improves HRV, oxygen saturation, athletic recovery, or metabolic health are not established by the direct evidence base.
3 sources / 3 studies
Integrity
80/100
Supported With Boundaries
Children who snore, mouth breathe, or seem to need mouth taping should be evaluated for airway, allergy, dental, or sleep issues rather than treated as biohack candidates.
3 sources / 3 studies
Integrity
68/100
Partly Supported / Context-Dependent
Mouth closure strategies can be relevant in narrow CPAP leak or mouth-breathing contexts, but that is different from unsupervised mouth taping as a general sleep hack.
3 sources / 3 studies
Integrity
58/100
Partly Supported / Context-Dependent
The claim that most people in high-income settings are carrying hidden parasites is unsupported without exposure history, organism-specific symptoms, or appropriate diagnostic testing.
3 sources / 3 studies
Integrity
65/100
Partly Supported / Context-Dependent
Stringy material, mucus, undigested food, or unusual shapes in stool photos do not reliably prove worms or parasites without laboratory identification or clinician-directed testing.
3 sources / 3 studies
Integrity
70/100
Supported With Boundaries
Vague symptoms such as fatigue, bloating, itching, cravings, skin changes, or mood shifts should not be treated as parasite evidence without exposure context and organism-specific evaluation.
3 sources / 3 studies
Integrity
55/100
Partly Supported / Context-Dependent
Herbal parasite cleanse protocols are not supported as broad deworming treatments for the general public and should not replace organism-specific antiparasitic care when infection is suspected.
4 sources / 4 studies
Integrity
73/100
Supported With Boundaries
Natural parasite cleanse products are not automatically safe because herbal and dietary supplements can carry liver, drug-interaction, contamination, dosing, and delayed-care risks.
3 sources / 3 studies
Integrity
55/100
Partly Supported / Context-Dependent
Feeling worse during a parasite cleanse is not proof of parasite die-off because symptoms can reflect laxative effects, dehydration, electrolyte shifts, GI irritation, anxiety, or product adverse effects.
3 sources / 3 studies
Integrity
51/100
Uncertain Claim
Full-moon parasite cleanse schedules are not supported by clinical evidence as a timing strategy for diagnosing or treating human parasite infections.
3 sources / 3 studies
Integrity
75/100
Supported With Boundaries
The claim that conventional clinicians universally ignore parasites is misleading because real parasite infections have established diagnostic and treatment pathways, even though individual cases can still be missed.
4 sources / 4 studies
Integrity
50/100
Uncertain Claim
Parasite cleanse protocols are not established heavy-metal detox treatments and should not be marketed as a substitute for validated toxicology evaluation or medically supervised treatment.
3 sources / 3 studies
Integrity
79/100
Supported With Boundaries
Parasite cleanses should not replace evidence-based antiparasitic treatment when a real infection is diagnosed or strongly suspected.
4 sources / 4 studies
Integrity
87/100
Strongly Supported Claim
Raw milk is not safer than pasteurized milk because pasteurization is designed to reduce disease-causing germs while preserving milk’s nutritional role.
4 sources / 4 studies
Integrity
81/100
Supported With Boundaries
Pasteurization does not meaningfully destroy the major nutritional value of milk, so nutrition-loss claims do not outweigh the safety function of pathogen reduction.
3 sources / 3 studies
Integrity
79/100
Supported With Boundaries
Raw milk is not established as a treatment for lactose intolerance because raw cow’s milk still contains lactose and consumer tolerance claims are not the same as controlled digestive evidence.
3 sources / 3 studies
Integrity
70/100
Supported With Boundaries
Farm-milk allergy and asthma observations do not justify recommending retail raw milk because the observational farm-exposure signal is not equivalent to proving raw milk is a safe allergy-prevention intervention.
3 sources / 3 studies
Integrity
81/100
Supported With Boundaries
Clean farm practices can reduce raw-milk contamination risk but cannot guarantee raw milk is free of pathogens because contamination can occur despite good practices.
3 sources / 3 studies
Integrity
56/100
Partly Supported / Context-Dependent
Raw milk is not established as a safe immune-building food for the general public because claimed immune benefits remain weaker than the documented pathogen-risk boundary.
3 sources / 3 studies
Integrity
88/100
Strongly Supported Claim
Children are a higher-risk group for serious illness from raw milk pathogens, making child-focused raw-milk recommendations materially different from adult food-choice arguments.
3 sources / 3 studies
Integrity
80/100
Supported With Boundaries
Drinking raw milk as an H5N1 immunity strategy is not supported and can create infection risk rather than a reliable protective immune response.
3 sources / 3 studies
Integrity
87/100
Strongly Supported Claim
Raw milk outbreak risk is not theoretical because unpasteurized milk and raw-milk products have repeatedly been linked to foodborne illness outbreaks.
4 sources / 4 studies
Integrity
77/100
Supported With Boundaries
Food-freedom arguments do not settle the health-evidence question because legal access, personal autonomy, and pathogen risk are related but separate lanes.
3 sources / 3 studies
Integrity
85/100
Strongly Supported Claim
Adrenal fatigue is not a recognized medical diagnosis, and vague symptoms should not be treated as proof that the adrenal glands are exhausted.
3 sources / 3 studies
Integrity
70/100
Supported With Boundaries
Cortisol can relate to appetite, fat distribution, and stress physiology, but social-media cortisol-belly claims overstate what body shape alone can reveal.
3 sources / 3 studies
Integrity
66/100
Partly Supported / Context-Dependent
Face-shape changes should not be interpreted as cortisol proof because swelling, weight change, medication effects, sleep, alcohol, inflammation, and endocrine disease require different explanations.
3 sources / 3 studies
Integrity
56/100
Partly Supported / Context-Dependent
Adrenal or cortisol cocktails are not established treatments for abnormal cortisol physiology, adrenal fatigue, or chronic stress symptoms.
3 sources / 3 studies
Integrity
72/100
Supported With Boundaries
Ashwagandha has limited human evidence for stress or anxiety outcomes, but that does not make it a universal cortisol fix or risk-free adrenal treatment.
3 sources / 3 studies
Integrity
78/100
Supported With Boundaries
Routine cortisol testing for vague wellness symptoms can mislead when it is not tied to a validated clinical question, timing protocol, and differential diagnosis.
3 sources / 3 studies
Integrity
73/100
Supported With Boundaries
Coffee does not destroy the adrenal glands, although caffeine timing, dose, anxiety, sleep, blood pressure, reflux, and individual tolerance can matter.
3 sources / 3 studies
Integrity
68/100
Partly Supported / Context-Dependent
High-intensity exercise can raise cortisol acutely, but that does not prove HIIT causes fat gain through cortisol in otherwise appropriate training contexts.
3 sources / 3 studies
Integrity
73/100
Supported With Boundaries
Morning light can support circadian timing, but social-media claims that sunlight simply resets cortisol often overcompress sleep, light exposure, and stress physiology.
3 sources / 3 studies
Integrity
79/100
Supported With Boundaries
Adrenal support supplements can create safety risk when products contain undisclosed thyroid or steroid hormone activity or when users self-treat symptoms without diagnosis.
3 sources / 3 studies
Integrity
83/100
Supported With Boundaries
The broad claim that cannabis shrinks your brain overstates a mixed evidence base and swaps endpoints such as perfusion, activation, volume, and cognition.
10 sources / 7 studies
Integrity
78/100
Supported With Boundaries
Heavy lifetime cannabis use has been associated with lower working-memory task activation in young-adult fMRI data.
1 sources / 1 studies
Integrity
82/100
Supported With Boundaries
Cannabis brain-volume evidence varies by population, exposure pattern, age at first use, co-use, measurement method, and confounding.
2 sources / 2 studies
Integrity
81/100
Supported With Boundaries
A SPECT perfusion or blood-flow finding should not be described as proof of structural brain shrinkage.
1 sources / 1 studies
Integrity
85/100
Strongly Supported Claim
Cannabis brain and cognition risk depends heavily on age, frequency, potency, recency, route, dependence, vulnerability, and co-use.
2 sources / 2 studies
Integrity
86/100
Strongly Supported Claim
Ketamine should not be framed as a casual relaxation substitute for cannabis; FDA warns about meaningful safety and monitoring concerns for compounded ketamine products.
1 sources / 1 studies
Integrity
79/100
Supported With Boundaries
Older-adult cannabis brain-volume counter-signals break the simple shrinkage meme but do not prove cannabis protects the aging brain.
2 sources / 1 studies
Vital Signals
Get the weekly health signal without the wellness fog.
A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.
No spam. No selling your information. Unsubscribe anytime.
By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.
